Skip to main content
OpenTrials
Completed

NCT Number: NCT04924777

Effects of Moderate Physical Activity on Glycemic Control in Type 2 Diabetes Mellitus

The study design is to determine the effectiveness of moderate physical activity on g;lycemic control in type 2 diabetes mellitus.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Type 2 Diabetes Mellitus Diabetes Mellitus Diabetes Mellitus, Type 2 Endocrine System Diseases Glucose Metabolism Disorders Metabolic Diseases Nutritional and Metabolic Diseases

Age range

30 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Riphah Rehabilitation Center

Islamabad, 44000, Pakistan

About this study

To the best of authors knowledge so far the studies have been conducted on different modes of moderate physical activity on glycemic control in type 2 diabetes, current study goal is to evaluate which mode of moderate physical activity has more significant result on glycemic control in type 2 diabetes and is sustainable in Pakistani society according to the socioeconomic status and cost effectiveness of the modes of moderate physical activity.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Participants falling in this category would be recruited into the study.
  • Male/female
  • Diabetic type 2 patients
  • Age: 30-70 years
  • BMI >25
  • Overweight
  • Fat % in male> 25
  • Fat % in female >35
  • HbA1c level more than 48mmol/mol or >6.5%
  • Fasting Plasma Glucose level >126 mg/dl (7.0 mmol/l)
  • Random Plasma glucose level >200 mg/dl (11.1 mmol/l)
  • Physically active ( have no mobility problems)

Exclusion criteria

  • Participant failing to fall in this category would be excluded of the study.
  • Type 1 diabetes
  • Insulin dependant type 2 diabetes
  • Gestational Diabetes
  • Hypertension
  • Cigarette smoking
  • Cardiovascular Disease
  • Cerebrovascular disease
  • Cardiopulmonary Disorders
  • Cognition Problems
  • Peripheral Artery Disease
  • Dyslipidemia
  • Proliferative or preproliferative retinopathy
  • Nephropathy
  • Neuropathy

Treatment and study plan

Brisk Walk

Other

1-Brisk walk for 30 minutes 2-5 days a week 3-3months

Strength training

Other

1-Strength Training Exercises for 30 minutes. 2-5 days a week 3-3 months

aerobic exercises

Other

1-Aerobic exercises for 30 minutes 2-5 Days a week 3-3months

Primary outcomes

  1. HbA1c Levels

    Time frame: 3 months

    Reduction in HbA1c levels

Sponsors and collaborators

Lead sponsor

Riphah International University

Other

Registry information

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Jun 14, 2021
Registry last updated
Nov 26, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.